Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Asset Acquisition [Table] Asset Acquisition [Table] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Diluted Document Fiscal Year Focus Document Fiscal Year Focus Class of warrant or right, conversion terms, threshold trading days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Adjustment to Compensation, Amount Adjustment to Compensation Amount Loan Facility, June 30, 2025 Loan Facility, June 30, 2025 [Member] Loan Facility, June 30, 2025 Number of Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Conversion of stock, shares issued (in shares) Conversion of Stock, Shares Issued SOFR floor Debt Instrument, Minimum Variable Rate, SOFR Floor Debt Instrument, Minimum Variable Rate, SOFR Floor Common stock, $0.0001 par value, 400,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively; 61,469,572 shares and 49,997,836 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Schedule of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Exit fee percentage Line Of Credit Facility, Exit Fee Percentage Line Of Credit Facility, Exit Fee Percentage Leases Lessee, Finance Leases [Text Block] Restatement Determination Date Restatement Determination Date Warrants issued, delayed draw commitment amount, percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Class Of Warrant Or Right, Warrants Issued, Delayed Draw Commitment Amount, Percentage Nature of Business [Line Items] Nature of Business [Line Items] Nature of Business [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Revenue base redemption liability Revenue Base Redemption Liability Revenue Base Redemption Liability Warrants to purchase common stock (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Beginning Balance Ending Balance Accounts Receivable, Allowance for Credit Loss Loan Facility, Initial Commitment Amount Loan Facility, Initial Commitment Amount [Member] Loan Facility, Initial Commitment Amount Amendment flag Amendment Flag Current liabilities Liabilities, Current [Abstract] Preferred stock converted (in shares) Conversion of Stock, Shares Converted Amount charged (reversed) to costs and expenses Accounts Receivable, Credit Loss Expense (Reversal) Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Payments on finance lease liabilities Finance Lease, Principal Payments Class of Warrant or Right [Table] Class of Warrant or Right [Table] 24 to 36 Months Prepayment Premium Rate, Period Three [Member] Prepayment Premium Rate, Period Three Purchase agreement, maximum shares allowed, percentage of average daily volume Common Stock, Share Price, Percentage Of Average Daily Volume Common Stock, Share Price, Percentage Of Average Daily Volume Leases [Abstract] Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Released, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Released, Weighted Average Grant Date Fair Value Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Original issue price (in dollars per share) Preferred Stock, Issued Price Per Share Preferred Stock, Issued Price Per Share Paid-in-kind interest Debt Instrument, Paid-In-Kind Interest Percentage Debt Instrument, Paid-In-Kind Interest Percentage PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Asset Acquisition [Axis] Asset Acquisition [Axis] Beginning balance Ending balance Fair Value, Measurement Reconciliation, Liability Value Fair Value, Measurement Reconciliation, Liability Value Number of shares outstanding Beginning Outstanding (in shares) Ending Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Reserve for obsolete inventory Inventory Valuation Reserves Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Maximum shares of common stock allowed under purchase agreement (in shares) Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Class of warrant or right, redemption price (in dollars per share) Class of Warrant or Right, Redemption Price Class of Warrant or Right, Redemption Price Entity Address, City or Town Entity Address, City or Town Upfront payment Asset Acquisition, Consideration Transferred Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Document Information [Line Items] Document Information [Line Items] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Proceeds from the issuance of common stock through employee stock purchase plan Proceeds from Stock Plans Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Line of credit, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Derivative Instrument, Period Two Derivative Instrument, Period Two [Member] Derivative Instrument, Period Two Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Recently Adopted Accounting Pronouncements And Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Non-cash capital expenditures included in trade payables Capital Expenditures Incurred but Not yet Paid Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Use of Estimates Use of Estimates, Policy [Policy Text Block] Dynavax Purchase Asset Acquisition [Text Block] Amortization of debt issuance costs Amortization of debt issuance costs Amortization of Debt Issuance Costs Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Schedule of Changes in Fair Value of Outstanding Warrant and Tranche Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Number of leases Lessee, Number Of Operating Leases Lessee, Number Of Operating Leases Research and Development Research and Development Expense, Policy [Policy Text Block] Long-term debt, beginning balance Long-term debt, ending balance Long-Term Debt Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Revenue base redemption liability Product Revenue Base Redemption [Member] Product Revenue Base Redemption Supplemental disclosures of cash flow information Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Document Period End Date Document Period End Date Changes in operating assets and liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Threshold number of business days before sending notice of redemption to warrant holders Class Of Warrant Or Right, Conversion Days Notice Class Of Warrant Or Right, Conversion Days Notice Private Placement Warrants - Level 2 Private Placement Warrants Private Warrants [Member] Private Warrants Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Preferred Stock, Shares Outstanding Conversion of Stock, Name [Domain] Conversion of Stock, Name [Domain] Nature of Business [Table] Nature of Business [Table] Nature of Business [Table] Security Exchange Name Security Exchange Name Default rate Debt Instrument, Debt Default, Rate Debt Instrument, Debt Default, Rate Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Convertible Preferred Stock Preferred Stock [Text Block] Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Outstanding, Number Entity Shell Company Entity Shell Company Change in Fair Value (Gains) Losses Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Options and RSUs outstanding (in shares) Authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Schedule of Accounts Receivable, Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss [Table Text Block] Undeclared cumulative dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Preferred Stock Dividends, Undeclared Cumulative Dividends Segment Reporting Segment Reporting, Policy [Policy Text Block] Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Common stock, shares authorized for SEPA agreement (in shares) Common Stock, Shares Authorized, Standby Equity Purchase Agreement Common Stock, Shares Authorized, Standby Equity Purchase Agreement Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Contingent earnout liability Contingent earnout liability Contingent Earnout Liability [Member] Contingent Earnout Liability Class of warrant or right, conversion terms, threshold consecutive trading days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Purchase agreement, sales price, percentage of market price during three consecutive trading days Share Price As Percentage Of Market Price With Advance Notice, Option Two Share Price As Percentage Of Market Price With Advance Notice, Option Two Income Tax Disclosure [Abstract] Amortization of debt issuance costs and discounts Amortization of Debt Issuance Costs and Discounts Number of leases entered into during period Lessee, Number Of Finance Leases Entered Into During Period Lessee, Number Of Finance Leases Entered Into During Period Commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Depreciation Depreciation, Depletion and Amortization, Nonproduction Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Weighted average common shares outstanding, diluted (in shares) Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Warrant Warrant [Member] Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Product revenue base, minimum amount required Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Line Of Credit Facility, Product Revenue Base, Minimum Threshold Amount Underlying Security Market Price Change Underlying Security Market Price Change, Percent Temporary Equity Disclosure [Abstract] Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Standby Equity Purchase Agreement Derivative Instruments and Hedging Activities Disclosure [Text Block] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Gross profit Gross Profit Shares issuable under the SEPA Standby Equity Purchase Agreement (SEPA) [Member] Standby Equity Purchase Agreement (SEPA) Royalties as a percentage of net sales, under sales threshold Asset Acquisition, Royalty Percentage, Under Threshold Amount Asset Acquisition, Royalty Percentage, Under Threshold Amount Award Timing Predetermined Award Timing Predetermined [Flag] Aggregate intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Change in fair value of SEPA, warrant and revenue base redemption liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Gain (Loss) On Change In Fair Value Of Warrants And Other Liabilities Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Restricted Stock Units (RSUs) And Performance Share Units (PSUs) Restricted Stock Units (RSUs) And Performance Share Units (PSUs) [Member] Restricted Stock Units (RSUs) And Performance Share Units (PSUs) Exercise price Measurement Input, Exercise Price [Member] Effective federal tax rate Effective Income Tax Rate Reconciliation, Percent Organization, Consolidation and Presentation of Financial Statements [Abstract] Share-based compensation arrangement by share-based payment award, automatic increase, percentage of total shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Total Shares Dilutive awards outstanding (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Beginning Outstanding (in dollars per share) Ending Outstanding (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Fair value of long term debt Long-Term Debt, Fair Value Plan Name [Domain] Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Asset Acquisition [Domain] Asset Acquisition [Domain] Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Sales and marketing Selling and Marketing Expense Right-of-use assets Operating Lease, Right-of-Use Asset Number of revenue bases Line Of Credit Facility, Product Revenue Base, Thresholds Lowered During Modification Line Of Credit Facility, Product Revenue Base, Thresholds Lowered During Modification Conversion price (in dollars per share) Preferred Stock, Convertible, Conversion Price Finance lease expense: Finance Lease, Liability [Abstract] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Fixed assets purchased through exchange of finance lease right-of-use asset Fixed Assets Purchased Through Exchange Of Finance Lease Right-Of-Use Asset Fixed Assets Purchased Through Exchange Of Finance Lease Right-Of-Use Asset Minimum Minimum [Member] Number of finance leases Lessee, Number Of Finance Leases Lessee, Number Of Finance Leases Expiration Date Trading Arrangement Expiration Date Liabilities Liabilities [Abstract] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Stock Options and Restricted Stock Units Stock Options and Restricted Stock Units [Member] Stock Options and Restricted Stock Units Earnout period, threshold trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Exercisable, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Share-based compensation arrangement by share-based payment award, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Derivative [Table] Derivative [Table] Proceeds from the issuance of common stock, net of issuance costs Proceeds from Issuance of Common Stock Common stock, shares authorized (in shares) Common Stock, Shares Authorized Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Sale of stock (in shares) Sale of Stock, Number of Shares Issued in Transaction Royalties as a percentage of sales, over threshold amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Exercise Price Award Exercise Price Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Temporary Equity [Line Items] Temporary Equity [Line Items] Maximum aggregate milestone payments per development milestone Asset Acquisition, Maximum Milestone Amount Asset Acquisition, Maximum Milestone Amount Debt Debt Disclosure [Text Block] Liquidation preference (in dollars per share) Preferred Stock, Liquidation Preference Per Share Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Prepayment Premium Rate, Period [Domain] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Secured Debt Secured Debt [Member] Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Trade payables Accounts Payable, Trade, Current Net proceeds on sale of stock Sale of Stock, Consideration Received on Transaction Adoption Date Trading Arrangement Adoption Date Total stockholders’ equity (deficit) Balance, beginning of period Balance, end of period Equity, Attributable to Parent Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Issuances (Settlements) Fair Value, Measurement Reconciliation, Liability, Purchases, (Sales), Issuances, (Settlements) Fair Value, Measurement Reconciliation, Liability, Purchases, (Sales), Issuances, (Settlements) Common stock issuance costs Payments of Stock Issuance Costs Insider Trading Policies and Procedures [Line Items] Stock options outstanding (in shares) Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Dynavax Technologies Dynavax Technologies [Member] Dynavax Technologies Accounts receivable, allowance for credit loss, current Accounts Receivable, Allowance for Credit Loss, Current Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Performance Shares Performance Shares [Member] Actual undeclared dividends Preferred Stock Dividends, Undeclared Actual Dividends Preferred Stock Dividends, Undeclared Actual Dividends SEPA liability Standby Equity Purchase Agreement (SEPA) Derivative Liability [Member] Standby Equity Purchase Agreement (SEPA) Derivative Liability Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Warrant liability Warrant Liability Warrant Liability Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Estimated dividend yield Dividend yield Measurement Input, Expected Dividend Rate [Member] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount RSUs and PSUs Restricted Stock Units (RSUs) [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key All Adjustments to Compensation All Adjustments to Compensation [Member] Stockholders’ equity (deficit) Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Income Statement [Abstract] Issuance of common stock through employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Released in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Released in Period Preferred stock, dividend rate, percentage Preferred Stock, Dividend Rate, Percentage Operating expenses: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] 2024 Stock-Based Compensation Awards 2024 Stock-Based Compensation Awards [Member] 2024 Stock-Based Compensation Awards Class of warrant or right, conversion terms, business days redemption notice period Class of Warrant or Right, Conversion Terms, Business Days Redemption Notice Period Class of Warrant or Right, Conversion Terms, Business Days Redemption Notice Period Number of Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Fair Value, Liabilities Measurement Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measurement Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measurement Reconciliation, Calculation City Area Code City Area Code Document Information [Table] Document Information [Table] All Individuals All Individuals [Member] Non-cash lease expense Operating Lease, Right-of-Use Asset, Periodic Reduction Expected share price volatility Measurement Input, Price Volatility [Member] Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period [Axis] Revenue Base Redemption Feature, Period Name Forgone Recovery, Individual Name Finished goods Inventory, Finished Goods, Net of Reserves Compensation expense, period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Contingent earnout liability Business Combination, Contingent Consideration, Liability, Noncurrent Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted-Average Grant-Date Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Line Items] Statement [Line Items] Total assets Assets Warrant liability, measurement input Warrant Liability, Measurement Input Warrant Liability, Measurement Input Accounts Receivable and Allowance for Credit Losses Accounts Receivable [Policy Text Block] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Total common stock available for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Standby equity purchase agreement term Standby Equity Purchase Agreement, Term Standby Equity Purchase Agreement, Term Warrants Warrant Liabilities [Text Block] Warrant Liabilities Interest expense Interest Expense, Nonoperating Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Issuance of common stock through employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Nature Of Business And Basis Of Presentation Nature of Operations [Text Block] Proceeds from the issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Recognized compensation expense Share-Based Payment Arrangement, Expense Number of additional shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Cash, Cash Equivalents, and Restricted Cash Cash and Cash Equivalents, Policy [Policy Text Block] Exercise of options and vesting of restricted stock units (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Preferred Stock Converted To Common Stock Preferred Stock Converted To Common Stock [Member] Preferred Stock Converted To Common Stock Earnout shares vesting percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Accumulated deficit Retained Earnings [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeiture (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Rebates recognized Revenue Recognition, Rebates Recognized Revenue Recognition, Rebates Recognized Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Balances, beginning of period (in shares) Balances, end of period (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Debt issuance costs Payments of Debt Issuance Costs Diluted loss per share (in dollars per share) Diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Working Capital Warrants - Level 2 Working Capital Warrants Working Capital Warrants [Member] Working Capital Warrants Total Shareholder Return Amount Total Shareholder Return Amount Allowance for credit losses Accounts Receivable, Credit Loss Expense (Reversal) Including Writeoffs Accounts Receivable, Credit Loss Expense (Reversal) Including Writeoffs Share-based compensation arrangement by share-based payment award, automatic increase, percentage of initial share reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase, Percentage of Initial Share Reserve Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Revenue Base Redemption Feature, Period [Domain] Proceeds from the issuance of debt Proceeds from Long-Term Lines of Credit Research and development Research and Development Expense Current stock price Stock price Measurement Input, Share Price [Member] OrbiMed Warrant liability OrbiMed Warrants OrbiMed Warrants [Member] OrbiMed Warrants Adjustments to reconcile net loss to net cash used in operating activities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Write-off of uncollectible receivables Accounts Receivable, Allowance for Credit Loss, Writeoff Revenue Revenue from Contract with Customer, Excluding Assessed Tax Undrawn fee, percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Initial OrbiMed Warrant Initial OrbiMed Warrant [Member] Initial OrbiMed Warrant Payment terms Accounts Receivable, Payment Terms Accounts Receivable, Payment Terms Royalties, sales threshold amount Asset Acquisition, Royalties, Sales Threshold Amount Asset Acquisition, Royalties, Sales Threshold Amount Percentage of preferred stock that were tendered Preferred Stock, Percentage Of Outstanding Stock Tendered Preferred Stock, Percentage Of Outstanding Stock Tendered Inventory Inventory Disclosure [Text Block] Exercise of options and vesting of restricted stock units Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Purchase agreement, number of trading days used for measurement of market price Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Proceeds from the issuance of common stock, net of issuance costs Stock Issued During Period, Value, New Issues Over-Allotment Option Over-Allotment Option [Member] Preferred stock conversion (in shares) Preferred Stock Conversion, Shares Preferred Stock Conversion, Shares Prepaid expenses Prepaid Expense, Current Forfeiture (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-Based Payment Arrangement, Performance-Based Option Share-Based Payment Arrangement, Performance-Based Option [Member] Share-Based Payment Arrangement, Performance-Based Option Preferred stock Preferred Stock [Member] Inventory, net Increase (Decrease) in Inventories Common stock warrants Common Stock Warrant [Member] Common Stock Warrant Stock options available for future grant (in shares) Available for Issue (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Sale of Stock [Axis] Sale of Stock [Axis] Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Aggregate Intrinsic Value (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Schedule of Lease Cost Lease, Cost [Table Text Block] Long-term lease liabilities Lease Liability, Noncurrent Lease Liability, Noncurrent Commitments and Contingencies Disclosure [Abstract] Other income (expense) Other Nonoperating Income (Expense) [Abstract] All Trading Arrangements All Trading Arrangements [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Change in fair value of SEPA, warrant and revenue base redemption liabilities Change in fair value of SEPA, warrant and revenue base redemption liabilities Derivative, Gain (Loss) on Derivative, Net Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Outstanding warrant liabilities Warrants and Rights Outstanding Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Derivative [Line Items] Derivative [Line Items] Contingent Earnout Liability Business Combination [Text Block] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Purchase agreement, exchange cap Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Standby Equity Purchase Agreement, Maximum Allowable Percentage Of Outstanding Common Stock Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Subsequent OrbiMed Warrants Subsequent OrbiMed Warrants [Member] Subsequent OrbiMed Warrants Class of warrant or right, threshold number of days for warrants to be transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Minimum liquidity cash requirement Debt Instrument, Covenants, Minimum Liquidity Cash Requirement Debt Instrument, Covenants, Minimum Liquidity Cash Requirement Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Share-based compensation arrangement by share-based payment award, automatic increase period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Share-Based Compensation Arrangement By Share-based Payment Award, Automatic Increase Period Share reserve increase, percent of fully diluted shares in previous year Share-Based Compensation Arrangement By Share-Based Payment Award, Increase As A Percent of Fully Diluted Shares in Previous Year Share-Based Compensation Arrangement By Share-Based Payment Award, Yearly Increase As a Percent of Fully Diluted Shares in Previous Year Derivative Instrument, Period Four Derivative Instrument, Period Four [Member] Derivative Instrument, Period Four Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Class of Stock [Line Items] Class of Stock [Line Items] Cash paid for income taxes Income Tax Paid, after Refund Received Stock Conversion Description [Axis] Stock Conversion Description [Axis] Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Change in Fair Value (Gains) Losses Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) Entity Small Business Entity Small Business Termination Date Trading Arrangement Termination Date Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other current liabilities Other Liabilities, Current Stock options, contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Other assets Other Assets, Noncurrent Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Accrued liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Paid-in-kind interest PIK interest Paid-in-Kind Interest Loss per share: Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Aggregate intrinsic value for options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Purchase agreement, sales price, percentage of market price Share Price As Percentage Of Market Price Commencing On Advance Notice Date Share Price As Percentage Of Market Price Commencing On Advance Notice Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Schedule of Performance Shares Activity Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Total finance lease expense Finance Lease, Cost Finance Lease, Cost Warrants and rights outstanding, term Warrants and Rights Outstanding, Term Commitments and contingencies (Note 13) Commitments and Contingencies Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Trade payables and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount December 31, 2026 and Each Fiscal Quarter ending thereafter Revenue Base Redemption Feature, Period Nine And Thereafter [Member] Revenue Base Redemption Feature, Period Nine And Thereafter Executive Category: Executive Category [Axis] Amortization of ROU assets Finance Lease, Right-of-Use Asset, Amortization Stock options, graded vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Liabilities and Stockholders’ Equity (Deficit) Liabilities and Equity [Abstract] Weighted average remaining contractual term, exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Fair value of warrants issued with OrbiMed debt Warrants Issued In Connection With Debt, Value Warrants Issued In Connection With Debt, Value Inventory, net Inventory, net Inventory, Net All Award Types Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Interest on lease liabilities Finance Lease, Interest Expense Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Financial Instruments Fair Value Disclosures [Text Block] 12 to 24 Months Prepayment Premium Rate, Period Two [Member] Prepayment Premium Rate, Period Two Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] PEO Name PEO Name Restricted cash Restricted Cash Paid in kind interest, term Debt Instrument, Paid-In-Kind Interest, Term Debt Instrument, Paid-In-Kind Interest, Term Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Contingent earnout liability, measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Interest expense Interest Expense, Debt Liability Class [Axis] Liability Class [Axis] June 30, 2026 Revenue Base Redemption Feature, Period Seven [Member] Revenue Base Redemption Feature, Period Seven Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Undeclared dividends on Series A Preferred Stock Preferred Stock Dividends, Income Statement Impact Derecognition of finance lease right-of-use asset Derecognition Of Finance Lease Right-Of-Use Asset Derecognition Of Finance Lease Right-Of-Use Asset Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Underwriting Offering Underwriting Offering [Member] Underwriting Offering Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Preferred stock available for future issuance (in shares) Preferred Stock, Capital Shares Reserved for Future Issuance Within 12 Months Prepayment Premium Rate, Period One [Member] Prepayment Premium Rate, Period One Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity [Roll Forward] Debt Instrument, Activity Debt Instrument [Axis] Debt Instrument [Axis] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Debt instrument, prepayment premium rate Debt Instrument, Prepayment Premium Rate Debt Instrument, Prepayment Premium Rate Issuances (Settlements) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) Total lease expense Lease, Cost After 48 Months Prepayment Premium Rate, Period Five [Member] Prepayment Premium Rate, Period Five Issuance of common stock for exchange warrants (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Number of upfront payment Asset Acquisition, Number of Upfront Payment Asset Acquisition, Number of Upfront Payment Shares issuable under ESPP Employee Stock [Member] Warrant redemption condition, share price (in dollars per share) Class Of Warrant Or Right, Conversion Stock Price Threshold Class Of Warrant Or Right, Conversion Stock Price Threshold Schedule of Components of Inventory Schedule of Inventory, Current [Table Text Block] Leases Lessee, Operating Leases [Text Block] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Basic loss per share (in dollars per share) Basic (in dollars per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Schedule of Plan Balances Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Shares unvested (in shares) Contingent Consideration, Liability, Shares Number of Shares Unvested Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Long-term debt Long-Term Debt, Excluding Current Maturities Class of warrant or right, ownership limitation Class Of Warrant Or Right, Ownership Limitation Class Of Warrant Or Right, Ownership Limitation Award Type Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable (net of allowance of $98 and $24, respectively) Accounts receivable, net of allowance for credit losses Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Retained Earnings (Accumulated Deficit) 2009 Plan 2009 Plan [Member] 2009 Plan Derivative Instrument, Period [Axis] Derivative Instrument, Period [Axis] Derivative Instrument, Period Change in fair value of contingent earnout liability Change in fair value of contingent earnout liability Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common stock, $0.0001 par value Common stock Common Stock [Member] Restricted Stock Units And Performance Shares Restricted Stock Units And Performance Shares [Member] Restricted Stock Units And Performance Shares Operating lease expense Operating Lease, Cost Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Shares purchased in ESPP offering (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Cover [Abstract] Public Warrants - Level 1 Public Warrants Public Warrants [Member] Public Warrants Short-swing profit settlement Proceeds from Short Swing Settlement Profit Proceeds from Short Swing Settlement Profit Sale of stock, authorized amount Sale Of Stock, Authorized Amount, Value Sale Of Stock, Authorized Amount, Value Equity Awards Adjustments Equity Awards Adjustments [Member] Asset Acquisition [Line Items] Asset Acquisition [Line Items] Total liabilities and stockholders’ equity (deficit) Liabilities and Equity Warrant liabilities Derivative Liability, Noncurrent Subsequent OrbiMed Warrants, Entity One Subsequent OrbiMed Warrants, Entity One [Member] Subsequent OrbiMed Warrants, Entity One Stock options Share-Based Payment Arrangement, Option [Member] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Loan Facility Loan Facility [Member] Loan Facility Inventory Disclosure [Abstract] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Other income (expense), net Other Nonoperating Income (Expense) Derivative Instrument, Period One Derivative Instrument, Period One [Member] Derivative Instrument, Period One Option to purchase additional shares Sale Of Stock, Over-Allotment Option, Period Sale Of Stock, Over-Allotment Option, Period Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Earnout shares vesting requirement, weighted average price per share (in dollars per share) Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger General and administrative General and Administrative Expense Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share 2023 Plan 2023 Plan [Member] 2023 Plan Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized 36 to 48 Months Prepayment Premium Rate, Period Four [Member] Prepayment Premium Rate, Period Four Commercial Milestone Commercial Milestone [Member] Commercial Milestone Preferred Stock, $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Subsequent OrbiMed Warrants, Entity Two Subsequent OrbiMed Warrants, Entity Two [Member] Subsequent OrbiMed Warrants, Entity Two Class of Stock [Domain] Class of Stock [Domain] Purchase agreement, ownership limitation Purchase Agreement, Ownership Limitation Purchase Agreement, Ownership Limitation Purchase agreement, number of days used for measurement of average daily trading volume Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Statement of Cash Flows [Abstract] Underwriting Agreement Underwriting Agreement [Member] Underwriting Agreement Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Payments for milestone Payments for Asset Acquisition, Milestone Amount Payments for Asset Acquisition, Milestone Amount Additional paid-in capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Supplemental disclosure of non-cash items Supplemental Cash Flow Elements [Abstract] Short-swing profit settlement Stock Issued During Period, Value, Short Swing Profit Settlement Stock Issued During Period, Value, Short Swing Profit Settlement Name Trading Arrangement, Individual Name Cash and cash equivalents Cash and Cash Equivalent Term Loans Term Loans [Member] Term Loans Expected term (years) Measurement Input, Expected Term [Member] Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Series A Convertible Preferred Stock Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock Raw materials Inventory, Raw Materials, Net of Reserves Short-term lease liabilities Lease Liability, Current Lease Liability, Current Commercial Milestone Type [Axis] Commercial Milestone Type [Axis] Commercial Milestone Type Company Selected Measure Amount Company Selected Measure Amount Weighted-Average Remaining Contractual Life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Life [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Life Stock, Class of Stock [Table] Stock, Class of Stock [Table] Earnout period, threshold consecutive trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Right-of-use assets obtained in exchange for new finance lease liabilities Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Derivative Instrument, Period Three Derivative Instrument, Period Three [Member] Derivative Instrument, Period Three Current assets Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Income tax benefit (expense) Income Tax Expense (Benefit) Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Cost of goods sold Cost of Product and Service Sold Award Timing Method Award Timing Method [Text Block] Increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Accretion of exit fee liability Accretion Expense Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period [Axis] Prepayment Premium Rate, Period Net loss Net income (loss) Net loss Net Income (Loss) Attributable to Parent Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] September 30, 2026 Revenue Base Redemption Feature, Period Eight [Member] Revenue Base Redemption Feature, Period Eight Proceeds from disposal of property and equipment Proceeds from Sale of Property, Plant, and Equipment Statement [Table] Statement [Table] Restatement Determination Date: Restatement Determination Date [Axis] Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Proceeds from the exercise of stock options for common stock Proceeds from Stock Options Exercised Interest income Investment Income, Interest Exercisable, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Standby Equity Purchase Agreement Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement Number of commercial milestones Asset Acquisition, Number of Commercial Milestones Asset Acquisition, Number of Commercial Milestones Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Loan Facility, December 31, 2025 Loan Facility, December 31, 2025 [Member] Loan Facility, December 31, 2025 Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract]